论文部分内容阅读
目的:探讨普萘洛尔治疗桥本病伴发甲亢82例临床疗效观察。方法:随机选取2010年04月份-2011年05月份因桥本病伴发甲亢就诊于我院的患者82例,随机分为治疗组41例患者(采用普萘洛尔治疗),对照组41例患者(采用常规治疗),统计两组患者的甲状腺功能以及影像学改变,并对结果进行统计分析。结果:治疗组总有效率为68.3%,甲状腺功能以及影像学检查结果均明显优于对照组,经统计分析,P<0.05,差异存在显著性。结论:普萘洛尔治疗桥本病伴发甲亢有效改善甲状腺功能,值得临床普遍使用。
Objective: To investigate the clinical efficacy of propranolol in the treatment of hypertriglycerideism associated with Hashimoto’s disease in 82 cases. Methods: 82 patients randomly selected from April 2010 to May 2011 due to Hashimoto’s disease with hyperthyroidism in our hospital were randomly divided into treatment group (n = 41) treated with propranolol and control group (n = 41) Patients (using conventional therapy), thyroid function and imaging changes in both groups were statistically analyzed and the results were statistically analyzed. Results: The total effective rate of the treatment group was 68.3%, thyroid function and imaging findings were significantly better than the control group, the statistical analysis, P <0.05, the difference was significant. Conclusion: Propranolol treatment of Hashimoto’s disease associated with hyperthyroidism effectively improve thyroid function, worthy of widespread clinical use.